Stockholm’s Brakket Invest Picks Up MENA-Based Tech Firm
Brakket Invest, a growth equity fund based in Stockholm and Dubai, signed an agreement this week to acquire BEON-IT, a SAP Gold-Partner firm with offices throughout the Middle East. The move will give Brakket Invest a foothold in the global tech industry as it gears up to launch its operations in Switzerland.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211006005013/en/
Stockholm’s Brakket Invest Picks Up MENA-Based Tech Firm (Photo: Business Wire)
“This acquisition confirms our commitment to fueling the growth of tech pioneers, especially in the GCC and DACH regions, where demand for SAP solutions continues to grow exponentially,” Brakket Group Managing Partner M. Hussein El Hakim says.
SAP is widely recognized as the global leader in enterprise software for the management of business operations.
BEON-IT: Digitalizing the Region’s SMEs
On October 6, 2020 a Big Four firm announced its acquisition of Tyconz Enterprise Business to expand its Technology and Digital Consulting Business. Tyconz’ SME business was excluded from the acquisition, and was later rebranded as Beon-IT.
With six offices across the region and a qualified team of over 50 Arabic-speaking experts, BEON-IT has served more than 200 blue-chip companies across the region, in a variety of industries like EC&O, manufacturing, retail, professional services and consumer goods.
Beon-IT CEO Shadi Abdelkhalek voiced his pleasure with the acquisition, which, he explained, would allow BEON-IT to achieve its full market potential. “We’re thrilled that the organization will be joining Brakket Invest, and are confident that the move will help it expand into new markets and offer its clients more innovative services,” he says.
Leveraging Booming Potential
With BEON-IT having been advised by Awad Capital Ltd., a DFSA regulated firm, and Brakket Invest’s expansive presence across the EMEA region, the new partnership abounds with growth potential. BEON-IT will now enjoy access to Brakket’s extensive SAP consulting expertise, diverse network of partners, and consolidated advisory resources.
“We’re particularly well-positioned to help BEON-IT realize its latent potential,” Brakket Invest’s el Hakim says. “This acquisition will enable us to solidify our tech capabilities as we join forces in the digital transformation of the region’s SMEs.”
Brakket Invest is a Dubai & Stockholm-based growth equity fund that invests in high-growth, high-potential ventures in deep-tech, Internet and consumer platforms, shaping & transforming them into tomorrow’s regional market leaders.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211006005013/en/
Contact information
M. Hussein el Hakim
+971 – 4313 2599
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Novaliq Receives FDA IND Clearance to Advance NOV05 in a Phase II Clinical Trial in Non-infectious Anterior Uveitis26.1.2026 15:00:00 EET | Press release
Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on its unique water-free EyeSol® drug category, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for NOV05, the company’s first IND for treating inner-eye diseases. NOV05, tacrolimus ophthalmic solution in EyeSol®, is a unique, steroid-free topical anti-inflammatory treatment. The IND clearance enables initiation of the EYETAC Phase II clinical trial in patients with non-infectious anterior uveitis (NIAU). Anterior uveitis is an inflammation of the inner eye including the iris and ciliary body, that typically causes a red, painful, light‑sensitive eye and can lead to vision loss if not treated promptly. NIAU represents 67-90% of uveitis cases in the developed world.1 To treat uveitis a drug must reach the uveal tract inside the eye. Current treatment choices are limited to corticosteroid eye drops and, if insuffic
Lucend, Formerly Coolgradient, Raises $3.3M to Bring Transparent AI to Data Centers to Increase Uptime and Reliability While Maximizing Efficiency26.1.2026 15:00:00 EET | Press release
Lucend today announced that it is bringing its transparent data center optimization to the U.S. market, helping enterprises illuminate complex operational environments and empowering data center operators, innovation officers, and sustainability officers with the intelligence they need to act with trust, accuracy, and confidence. Lucend’s Transparent AI platform connects to existing infrastructure, no new hardware required, to transform static systems into adaptive, self-learning environments. The software takes existing sensor data to see connections across 300 billion sensor readings. Lucend’s AI analyzes billions of data points daily and provides prescriptive recommendations. The intelligence that Lucend’s platform delivers “shows its work,” empowering operators and delivering verifiable impact across enterprise environments that demand both performance and trust. “Lucend’s Transparent AI platform analyzes billions of data points daily and provides prescriptive recommendations that
IQM Quantum Computers Appoints Jan Goetz as Sole CEO to Lead Next Phase of Global Growth26.1.2026 11:15:00 EET | Press release
IQM Quantum Computers, a global leader in full-stack superconducting quantum computers, today announced a transition from its Co-CEO structure to a single Chief Executive Officer model. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260126737805/en/ From left to right: Jan Goetz (Co-founder & CEO) and Søren Hein (Chief Operating Officer and Deputy CEO) Co-founder and current Co-CEO Dr Jan Goetz becomes sole CEO effective since January 1st, following a resolution passed by the IQM board. In addition, Dr Søren Hein has been appointed Chief Operating Officer and Deputy CEO. As part of the transition, Mikko Välimäki steps down from his commercial role following a successful tenure as Co-CEO. He will continue to support the company as an advisor until 31 March 2026 to ensure continuity and a smooth transition. “Our dual CEO approach has served IQM well over the past two years, and I want to thank Mikko Välimäki for his significan
Aesyra Demonstrates Significant Sleep Bruxism Reduction in Clinical Study26.1.2026 10:00:00 EET | Press release
Aesyra SA, a Swiss medtech company developing innovative digital therapeutics for dental and sleep-related disorders, today announced the successful completion of its clinical investigation evaluating the efficacy and safety of AesyBite™ Active, an intelligent oral appliance designed to treat and prevent sleep bruxism through biofeedback. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260126533019/en/ AesyBite Custom smart nightguard by Aesyra SA. The clinical investigation demonstrated that AesyBite™ Active achieved a statistically significant and clinically meaningful reduction in sleep bruxism activity, exceeding the predefined performance target. Strong and robust clinical outcomes In the study (Identifier: NCT06153810), involving 26 adult patients with confirmed sleep bruxism, activation of the AesyBite Active biofeedback system resulted in a 60.6% reduction in total sleep bruxism duration per hour compared to baseline
Franklin Templeton Aligns Alternative Credit Firms Under BSP Brand26.1.2026 09:58:00 EET | Press release
Franklin Templeton’s US and European alternative credit businesses, Benefit Street Partners and Alcentra, have now aligned under an updated Benefit Street Partners (BSP) brand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260123270080/en/ David Manlowe, CEO of Benefit Street Partners The move is the final step in BSP and Alcentra’s integration – two pioneering alternative credit firms that Franklin Templeton acquired in 2019 and 2022, respectively – and reflects increasing investor demand for a specialist global credit platform with expertise across the full spectrum of the asset class. A refreshed logo and new website domain accompany the brand alignment, and from this week Alcentra branded funds start to take on the BSP name.1 Overall, Franklin Templeton’s alternative credit platform – which also includes direct lender Apera – is on track to exceed $100 billion in AUM in 2026. According to new research also published tod
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom